title: Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer.
abstract: Squamous cell cancer of the head and neck (SCCHN) is a major contributor to morbidity and mortality worldwide. In recent years, inhibition of the epidermal growth factor receptor has become an established treatment strategy in SCCHN both in the up-front treatment and in the recurrent and metastatic setting. This review summarizes the most important developments of the recent past and provides an overview of newer developments.
authors.affiliation: Dana Farber Cancer Institute, Boston, MA, USA.
authors.forename: Jochen H
authors.initials: JH
authors.lastname: Lorch